Pradaxa gives clinicians a new tool for preventing strokes and
blood clots in patients with atrial fibrillation. Learn how it works,
who’s eligible to receive it, and how to administer it.
Brush up on your knowledge of these potentially life-saving drugs.
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
